Sector consensus Natera, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 14:34:36 10/07/2026 BST			5-day change	1st Jan Change
278.58 ^USD	-1.16%		+0.91%	+23.03%

06-19	Pirche Ag and Natera, Inc. Announce Partnership to Advance Transplant Medicine by Combining Pre-Transplant Risk Stratification and Post-Transplant Dd-Cfdna Monitoring	CI
06-18	Natera Showcases Prospera Test Utility with 21 Presentations At American Transplant Congress	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
NATERA, INC.			271.24	-3.77%	21
LABCORP HOLDINGS INC.			311	+12.02%	17
SONIC HEALTHCARE LIMITED			24.13	+12.98%	16
RADNET, INC.			89.75	+36.11%	8
DR. LAL PATHLABS LIMITED			1,713.88	+1.74%	26
GENEDX HOLDINGS CORP.			78.44	+13.05%	9
NEOGENOMICS, INC.			15.11	+2.59%	9
DIAN DIAGNOSTICS GROUP CO.,LTD.			18.84	+2.74%	6
FLEURY S.A.			17.32	+9.95%	12
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.			30.49	+33.19%	6
VIJAYA DIAGNOSTIC CENTRE LIMITED			1,379.2	+0.1%	10
METROPOLIS HEALTHCARE LIMITED			614.2	+9.67%	19
H.U. GROUP HOLDINGS, INC.			3,156.67	-5.69%	3
OPKO HEALTH, INC.			4.375	+214.75%	4
THYROCARE TECHNOLOGIES LIMITED			603	+12.82%	5
BML, INC.	-	-	3,800	+3.83%	1
NOVOGENE CO., LTD.			17.25	+35.72%	2
ARTRYA LIMITED			6.14	+7.72%	3
FULGENT GENETICS, INC.	-	-	15	-28.16%	1
SMO CLINPLUS CO.,LTD.	-	-	-	-	-
Average			640.32	+19.54%	9
Weighted average by Cap.			355.8	+8.06%	17